Overview

Equivalence Study of Dorzolamide 2% Eye Drops Solution

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The study aims to prospectively prove the equivalence of the test product and the reference solution in lowering intraocular pressure in patients with open angle glaucoma and ocular hypertension. For this purpose the patients are randomized into two sequences of study drug administration in a crossover study with an adequate wash-out period.
Phase:
Phase 3
Details
Lead Sponsor:
Alfred E. Tiefenbacher (GmbH & Co. KG)
Treatments:
Dorzolamide
Ophthalmic Solutions
Pharmaceutical Solutions
Tetrahydrozoline